Fulgent Genetics (FLGT) Receivables - Other (2016 - 2025)

Fulgent Genetics has disclosed Receivables - Other across 10 years of filings, most recently posting $1.4 million for Q3 2025.

• Receivables - Other for Q3 2025 came in at $1.4 million, up 10.39% year-over-year; the trailing twelve-month figure through Sep 2025 was $1.4 million (up 10.39% YoY), and the FY2024 annual result was $1.8 million, changed N/A from the prior year.
• Receivables - Other came in at $1.4 million for Q3 2025 at Fulgent Genetics, down from $2.1 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $19.8 million in Q4 2022 to a low of $66000.0 in Q1 2023.
• The 5-year median for Receivables - Other is $1.2 million (2024), against an average of $2.1 million.
• Across the five-year window, Receivables - Other plunged 93.35% in 2023 and jumped 1513.64% in 2024, its largest moves.
• Fulgent Genetics' Receivables - Other stood at $1.4 million in 2021, then surged by 1313.83% to $19.8 million in 2022, then slumped by 93.35% to $1.3 million in 2023, then soared by 34.04% to $1.8 million in 2024, then declined by 20.7% to $1.4 million in 2025.
• The last three Receivables - Other figures came in at $1.4 million (Q3 2025), $2.1 million (Q2 2025), and $2.5 million (Q1 2025), per Business Quant data.